Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia

Molecular Psychiatry

Volumn 22, Issue 6, 2017, Pages 792-801

  Devor, A ^a,b,c,d   Andreassen, O A ^d,e   Wang, Y ^a,d,e   Maki Marttunen T ^d,e   Smeland, O B ^d,e   Fan, C C ^a,b   Schork, A J ^f,g   Holland, D ^a   Thompson, W K ^g,h   Witoelar, A ^d,e   Chen, C H ^h   Desikan, R S ^b,i   McEvoy, L K ^b   Djurovic, S ^e,j   Greengard, P ^k   Svenningsson, P ^l   Einevoll, G T ^d,m   Dale, A M ^a,b,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF OSLO   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF BERGEN   (Norway)

^k ROCKEFELLER UNIVERSITY   (United States)

^l KAROLINSKA INSTITUTE   (Sweden)

^m NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; IONOTROPIC RECEPTOR; PHOSPHOPROTEIN DARPP 32; 4 AMINOBUTYRIC ACID; DOPAMINE; METABOTROPIC RECEPTOR;

BRAIN; BRAIN FUNCTION; CELL MEMBRANE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC DATABASE; GENETICS; HUMAN; HUMAN BRAIN TRANSCRIPTOME PROJECT DATABASE; HYPOTHESIS; INTRACELLULAR SIGNALING; ION TRANSPORT; NERVE CELL EXCITABILITY; NEUROANATOMY; NEUROBIOLOGY; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SCHIZOPHRENIA; SYNAPSE; SYNAPTIC TRANSMISSION; GENETIC PREDISPOSITION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; METABOLISM; MULTIFACTORIAL INHERITANCE; RISK FACTOR; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

BRAIN; DOPAMINE; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; GAMMA-AMINOBUTYRIC ACID; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MULTIFACTORIAL INHERITANCE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IONOTROPIC GLUTAMATE; RECEPTORS, METABOTROPIC GLUTAMATE; RISK FACTORS; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 85016106888     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2017.33     Document Type: Review

References (84)

1. Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR, Davies NJ, et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry 1999; 56: 162-168.
2. Ripke S, O'Dushlaine C, Chambert K, Moran JL, Kahler AK, Akterin S, et al. Genomewide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 2013; 45: 1150-1159.
3. Sullivan PF. The psychiatric GWAS consortium: big science comes to psychiatry. Neuron 2010; 68: 182-186.
4. Cross-Disorder Group of the Psychiatric Genomics C. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013; 381: 1371-1379.
5. Schizophrenia Psychiatric Genome-Wide Association Study C. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011; 43: 969-976.
6. Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-Associated genetic loci. Nature 2014; 511: 421-427.
7. Schork AJ, Thompson WK, Pham P, Torkamani A, Roddey JC, Sullivan PF, et al. All SNPs are not created equal: genome-wide association studies reveal a consistent pattern of enrichment among functionally annotated SNPs. PLoS Genet 2013; 9: e1003449.
8. Wang Y, Thompson WK, Schork AJ, Holland D, Chen CH, Bettella F, et al. Leveraging genomic annotations and pleiotropic enrichment for improved replication rates in schizophrenia GWAS. PLoS Genet 2016; 12: e1005803.
9. van Os J, Kapur S. Schizophrenia. Lancet 2009; 374: 635-645.
10. Moghaddam B, Javitt D. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 2012; 37: 4-15.
11. Nakazawa K, Zsiros V, Jiang Z, Nakao K, Kolata S, Zhang S, et al. GABAergic interneuron origin of schizophrenia pathophysiology. Neuropharmacology 2012; 62: 1574-1583.
12. Berridge MJ. Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia. Cell Tissue Res 2014; 357: 477-492.
13. Lidow MS. Calcium signaling dysfunction in schizophrenia: a unifying approach. Brain Res Brain Res Rev 2003; 43: 70-84.
14. Moises HW, Zoega T, Gottesman II. The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiatry 2002; 2: 8.
15. Berridge MJ. Calcium signalling remodelling and disease. Biochem Soc Trans 2012; 40: 297-309.
16. Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC, Greengard P. DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol 2004; 44: 269-296.
17. Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 2011; 63: 182-217.
18. Kang HJ, Kawasawa YI, Cheng F, Zhu Y, Xu X, Li M, et al. Spatio-Temporal transcriptome of the human brain. Nature 2011; 478: 483-489.
19. Network, Pathway Analysis Subgroup of Psychiatric Genomics C. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci 2015; 18: 199-209.
20. Pocklington AJ, Rees E, Walters JT, Han J, Kavanagh DH, Chambert KD, et al. Novel findings from CNVs implicate inhibitory and excitatory signaling complexes in schizophrenia. Neuron 2015; 86: 1203-1214.
21. Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P, et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 2014; 506: 185-190.
22. Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014; 506: 179-184.
23. Insel TR. Rethinking schizophrenia. Nature 2010; 468: 187-193.
24. McCarroll SA, Hyman SE. Progress in the genetics of polygenic brain disorders: significant new challenges for neurobiology. Neuron 2013; 80: 578-587.
25. Walaas SI, Aswad DW, Greengard P. A dopamine- And cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. Nature 1983; 301: 69-71.
26. Greengard P. The neurobiology of slow synaptic transmission. Science 2001; 294: 1024-1030.
27. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003; 4: 517-529.
28. Zamponi GW, Currie KP. Regulation of Ca(V)2 calcium channels by G protein coupled receptors. Biochim Biophys Acta 2013; 1828: 1629-1643.
29. Mothet JP, Parent AT, Wolosker H, Brady RO Jr., Linden DJ, Ferris CD, et al. D-Serine is an endogenous ligand for the glycine site of the N-methyl-D-Aspartate receptor. Proc Natl Acad Sci USA 2000; 97: 4926-4931.
30. Buraei Z, Yang J. Structure and function of the beta subunit of voltage-gated Ca(2) (+) channels. Biochim Biophys Acta 2013; 1828: 1530-1540.
31. Brennand KJ, Landek-Salgado MA, Sawa A. Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells. Biol Psychiatry 2014; 75: 936-944.
32. Kantrowitz JT, Javitt DC. N-methyl-D-Aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?. Brain Res Bull 2010; 83: 108-121.
33. Lips ES, Cornelisse LN, Toonen RF, Min JL, Hultman CM, International Schizophrenia C, et al. Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia. Mol Psychiatry 2012; 17: 996-1006.
34. Torkamani A, Topol EJ, Schork NJ. Pathway analysis of seven common diseases assessed by genome-wide association. Genomics 2008; 92: 265-272.
35. Holmans P, Green EK, Pahwa JS, Ferreira MA, Purcell SM, Sklar P, et al. Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am J Hum Genet 2009; 85: 13-24.
36. Solovieff N, Cotsapas C, Lee PH, Purcell SM, Smoller JW. Pleiotropy in complex traits: challenges and strategies. Nat Rev Genet 2013; 14: 483-495.
37. Cotsapas C, Voight BF, Rossin E, Lage K, Neale BM, Wallace C, et al. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet 2011; 7: e1002254.
38. Wagner GP, Zhang J. The pleiotropic structure of the genotype-phenotype map: the evolvability of complex organisms. Nat Rev Genet 2011; 12: 204-213.
39. Sivakumaran S, Agakov F, Theodoratou E, Prendergast JG, Zgaga L, Manolio T, et al. Abundant pleiotropy in human complex diseases and traits. Am J Hum Genet 2011; 89: 607-618.
40. Mirnics K, Middleton FA, Lewis DA, Levitt P. Delineating novel signature patterns of altered gene expression in schizophrenia using gene microarrays. Scientific World J 2001; 1: 114-116.
41. Mirnics K, Middleton FA, Lewis DA, Levitt P. The human genome: gene expression profiling and schizophrenia. Am J Psychiatry 2001; 158: 1384.
42. Mirnics K, Middleton FA, Lewis DA, Levitt P. Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci 2001; 24: 479-486.
43. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000; 28: 53-67.
44. Vawter MP, Barrett T, Cheadle C, Sokolov BP, Wood WH III, Donovan DM, et al. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull 2001; 55: 641-650.
45. Thomas EA. Molecular profiling of antipsychotic drug function: convergent mechanisms in the pathology and treatment of psychiatric disorders. Mol Neurobiol 2006; 34: 109-128.
46. Valjent E, Bertran-Gonzalez J, Bowling H, Lopez S, Santini E, Matamales M, et al. Haloperidol regulates the state of phosphorylation of ribosomal protein S6 via activation of PKA and phosphorylation of DARPP-32. Neuropsychopharmacology 2011; 36: 2561-2570.
47. Larkum M. A cellular mechanism for cortical associations: an organizing principle for the cerebral cortex. Trends Neurosci 2013; 36: 141-151.
48. Marenco S, Weinberger DR. The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev Psychopathol 2000; 12: 501-527.
49. Spitzer NC. Electrical activity in early neuronal development. Nature 2006; 444: 707-712.
50. Rinaldi T, Kulangara K, Antoniello K, Markram H. Elevated NMDA receptor levels and enhanced postsynaptic long-Term potentiation induced by prenatal exposure to valproic acid. Proc Natl Acad Sci USA 2007; 104: 13501-13506.
51. Rinaldi T, Silberberg G, Markram H. Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid. Cereb Cortex 2008; 18: 763-770.
52. Markram H, Rinaldi T, Markram K. The intense world syndrome-An alternative hypothesis for autism. Front Neurosci 2007; 1: 77-96.
53. Adams RA, Stephan KE, Brown HR, Frith CD, Friston KJ. The computational anatomy of psychosis. Front Psychiatry/Front Res Found 2013; 4: 47.
54. Brandon NJ, Sawa A. Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci 2011; 12: 707-722.
55. Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery. Am J Hum Genet 2012; 90: 7-24.
56. Gaj T, Sirk SJ, Shui SL, Liu J. Genome-editing technologies: principles and applications. Cold Spring Harb Perspect Biol 2016; 8: pii: a023754.
57. Kramer RH, Mourot A, Adesnik H. Optogenetic pharmacology for control of native neuronal signaling proteins. Nat Neurosci 2013; 16: 816-823.
58. Spangler SM, Bruchas MR. Optogenetic approaches for dissecting neuromodulation and GPCR signaling in neural circuits. Curr Opin Pharmacol 2016; 32: 56-70.
59. Roth BL. DREADDs for neuroscientists. Neuron 2016; 89: 683-694.
60. Tenner B, Mehta S, Zhang J. Optical sensors to gain mechanistic insights into signaling assemblies. Curr Opin Struct Biol 2016; 41: 203-210.
61. Devor A, Bandettini PA, Boas DA, Bower JM, Buxton RB, Cohen LB, et al. The challenge of connecting the dots in the B.R.A.I.N. Neuron 2013; 80: 270-274.
62. Zhang H, Reichert E, Cohen AE. Optical electrophysiology for probing function and pharmacology of voltage-gated ion channels. Elife 2016; 5: e15202.
63. Mariani J, Simonini MV, Palejev D, Tomasini L, Coppola G, Szekely AM, et al. Modeling human cortical development in vitro using induced pluripotent stem cells. Proc Natl Acad Sci USA 2012; 109: 12770-12775.
64. Pasca AM, Sloan SA, Clarke LE, Tian Y, Makinson CD, Huber N, et al. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat Methods 2015; 12: 671-678.
65. Espuny-Camacho I, Michelsen KA, Gall D, Linaro D, Hasche A, Bonnefont J, et al. Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo. Neuron 2013; 77: 440-456.
66. Robertson HR, Feng G. Annual Research Review: transgenic mouse models of childhood-onset psychiatric disorders. J Child Psychol Psychiatry 2011; 52: 442-475.
67. Geyer MA, Olivier B, Joels M, Kahn RS. From antipsychotic to anti-schizophrenia drugs: role of animal models. Trends Pharmacol Sci 2012; 33: 515-521.
68. Porteous DJ, Millar JK, Brandon NJ, Sawa A. DISC1 at 10: connecting psychiatric genetics and neuroscience. Trends Mol Med 2011; 17: 699-706.
69. Clapcote SJ, Lipina TV, Millar JK, Mackie S, Christie S, Ogawa F, et al. Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 2007; 54: 387-402.
70. Wang XJ, Krystal JH. Computational psychiatry. Neuron 2014; 84: 638-654.
71. Maki-Marttunen T, Halnes G, Devor A, Witoelar A, Bettella F, Djurovic S, et al. Functional effects of schizophrenia-linked genetic variants on intrinsic singleneuron excitability: a modeling study. Biol Psychiatry Cogn Neurosci Neuroimag 2016; 1: 49-59.
72. Hill SL, Wang Y, Riachi I, Schurmann F, Markram H. Statistical connectivity provides a sufficient foundation for specific functional connectivity in neocortical neural microcircuits. Proc Natl Acad Sci USA 2012; 109: E2885-E2894.
73. Markram H, Muller E, Ramaswamy S, Reimann MW, Abdellah M, Sanchez CA, et al. Reconstruction and simulation of neocortical microcircuitry. Cell 2015; 163: 456-492.
74. Reimann MW, Anastassiou CA, Perin R, Hill SL, Markram H, Koch C. A biophysically detailed model of neocortical local field potentials predicts the critical role of active membrane currents. Neuron 2013; 79: 375-390.
75. Hagen E, Dahmen D, Stavrinou ML, Linden H, Tetzlaff T, van Albada SJ, et al. Hybrid scheme for modeling local field potentials from point-neuron networks. Cereb Cortex 2016; 26: 4461-4496.
76. Swerdlow NR, Braff DL, Geyer MA. Sensorimotor gating of the startle reflex: what we said 25 years ago, what has happened since then, and what comes next. J Psychopharmacol 2016; 30: 1072-1081.
77. Schork AJ, Wang Y, Thompson WK, Dale AM, Andreassen OA. New statistical approaches exploit the polygenic architecture of schizophrenia-implications for the underlying neurobiology. Curr Opin Neurobiol 2016; 36: 89-98.
78. Andreassen OA, Thompson WK, Schork AJ, Ripke S, Mattingsdal M, Kelsoe JR, et al. Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate. PLoS Genet 2013; 9: e1003455.
79. Le Hellard S, Wang Y, Witoelar A, Zuber V, Bettella F, Hugdahl K, et al. Identification of gene loci that overlap between schizophrenia and educational attainment. Schizophr Bull 2016: pii: sbw085 (e-pub ahead of print
80. Desikan RS, Schork AJ, Wang Y, Witoelar A, Sharma M, McEvoy LK, et al. Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus. Mol Psychiatry 2015; 20: 1588-1595.
81. Andreassen OA, Harbo HF, Wang Y, Thompson WK, Schork AJ, Mattingsdal M, et al. Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci. Mol Psychiatry 2015; 20: 207-214.
82. LeBlanc M, Zuber V, Andreassen BK, Witoelar A, Zeng L, Bettella F, et al. Identifying novel gene variants in coronary artery disease and shared genes with several cardiovascular risk factors. Circulation research 2016; 118: 83-94.
83. Andreassen OA, Zuber V, Thompson WK, Schork AJ, Bettella F, Consortium P, et al. Shared common variants in prostate cancer and blood lipids. Int J Epidemiol 2014; 43: 1205-1214.
84. Andreassen OA, Djurovic S, Thompson WK, Schork AJ, Kendler KS, O'Donovan MC, et al. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am J Hum Genet 2013; 92: 197-209.